[
  {
    "ts": null,
    "headline": "New Clinical Evidence Bolsters Hologic's Breast Cancer Technologies",
    "summary": "HOLX is set to present new real-world data at RSNA 2025, showing how its AI-driven breast imaging tools boost workflow without sacrificing detection.",
    "url": "https://finnhub.io/api/news?id=c666e80f3d536506020e28b7796ffd190e2f426c1f140795c0d839792abafb5c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764163080,
      "headline": "New Clinical Evidence Bolsters Hologic's Breast Cancer Technologies",
      "id": 137612723,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HOLX",
      "source": "Yahoo",
      "summary": "HOLX is set to present new real-world data at RSNA 2025, showing how its AI-driven breast imaging tools boost workflow without sacrificing detection.",
      "url": "https://finnhub.io/api/news?id=c666e80f3d536506020e28b7796ffd190e2f426c1f140795c0d839792abafb5c"
    }
  },
  {
    "ts": null,
    "headline": "US STD Diagnostics Market Forecast and Company Analysis 2025-2033 Featuring Abbott, F. Hoffmann-La Roche, Hologic, BD and Co, Danaher, Siemens, bioMerieux, Thermo Fisher Scientific, Qiagen, Bio-Rad",
    "summary": "The United States STD Diagnostics Market is set to grow from US$ 5.06 billion in 2024 to US$ 8.49 billion by 2033, achieving a CAGR of 5.91% from 2025 to 2033. Key growth drivers include rising STD prevalence, technological advancements, increased awareness, and supportive government initiatives. Rapid point-of-care tests and molecular diagnostics are gaining traction, while high costs and regulatory hurdles persist as challenges. Major markets like California, Texas, New York, and Florida lead",
    "url": "https://finnhub.io/api/news?id=8543e594ef4f6888b8a60fd6caa1d759c601038a6cd2405c9742a3e70a98035d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764152220,
      "headline": "US STD Diagnostics Market Forecast and Company Analysis 2025-2033 Featuring Abbott, F. Hoffmann-La Roche, Hologic, BD and Co, Danaher, Siemens, bioMerieux, Thermo Fisher Scientific, Qiagen, Bio-Rad",
      "id": 137611362,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HOLX",
      "source": "Yahoo",
      "summary": "The United States STD Diagnostics Market is set to grow from US$ 5.06 billion in 2024 to US$ 8.49 billion by 2033, achieving a CAGR of 5.91% from 2025 to 2033. Key growth drivers include rising STD prevalence, technological advancements, increased awareness, and supportive government initiatives. Rapid point-of-care tests and molecular diagnostics are gaining traction, while high costs and regulatory hurdles persist as challenges. Major markets like California, Texas, New York, and Florida lead",
      "url": "https://finnhub.io/api/news?id=8543e594ef4f6888b8a60fd6caa1d759c601038a6cd2405c9742a3e70a98035d"
    }
  }
]